Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

The absolute lymphocyte count can predict the overall survival of patients with non-small cell lung cancer on nivolumab: a clinical study.

Karantanos T, Karanika S, Seth B, Gignac G.

Clin Transl Oncol. 2019 Feb;21(2):206-212. doi: 10.1007/s12094-018-1908-2. Epub 2018 Jun 13.

PMID:
29948974
2.

Enzalutamide and CXCR7 inhibitor combination treatment suppresses cell growth and angiogenic signaling in castration-resistant prostate cancer models.

Luo Y, Azad AK, Karanika S, Basourakos SP, Zuo X, Wang J, Yang L, Yang G, Korentzelos D, Yin J, Park S, Zhang P, Campbell JJ, Schall TJ, Cao G, Li L, Thompson TC.

Int J Cancer. 2018 May 15;142(10):2163-2174. doi: 10.1002/ijc.31237. Epub 2018 Jan 30.

3.

Correlation of Opioid Mortality with Prescriptions and Social Determinants: A Cross-sectional Study of Medicare Enrollees.

Grigoras CA, Karanika S, Velmahos E, Alevizakos M, Flokas ME, Kaspiris-Rousellis C, Evaggelidis IN, Artelaris P, Siettos CI, Mylonakis E.

Drugs. 2018 Jan;78(1):111-121. doi: 10.1007/s40265-017-0846-6. Review.

PMID:
29159797
4.

Androgen receptor inhibitor-induced "BRCAness" and PARP inhibition are synthetically lethal for castration-resistant prostate cancer.

Li L, Karanika S, Yang G, Wang J, Park S, Broom BM, Manyam GC, Wu W, Luo Y, Basourakos S, Song JH, Gallick GE, Karantanos T, Korentzelos D, Azad AK, Kim J, Corn PG, Aparicio AM, Logothetis CJ, Troncoso P, Heffernan T, Toniatti C, Lee HS, Lee JS, Zuo X, Chang W, Yin J, Thompson TC.

Sci Signal. 2017 May 23;10(480). pii: eaam7479. doi: 10.1126/scisignal.aam7479.

5.

Pyogenic Liver Abscess Due to Fusobacterium nucleatum in a Patient With Liver Hemangiomas.

Karantanos T, Karanika S, Obiokoye K, Sullivan M, Phillips C, Ananthakrishnan S.

Am J Med Sci. 2017 Apr;353(4):417-418. doi: 10.1016/j.amjms.2016.07.008. Epub 2016 Aug 30. No abstract available.

PMID:
28317637
6.

The Attributable Burden of Clostridium difficile Infection to Long-Term Care Facilities Stay: A Clinical Study.

Karanika S, Grigoras C, Flokas ME, Alevizakos M, Kinamon T, Kojic EM, Mylonakis E.

J Am Geriatr Soc. 2017 Aug;65(8):1733-1740. doi: 10.1111/jgs.14863. Epub 2017 Mar 17.

PMID:
28306141
7.

Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 Signaling.

Karanika S, Karantanos T, Li L, Wang J, Park S, Yang G, Zuo X, Song JH, Maity SN, Manyam GC, Broom B, Aparicio AM, Gallick GE, Troncoso P, Corn PG, Navone N, Zhang W, Li S, Thompson TC.

Cell Rep. 2017 Feb 21;18(8):1970-1981. doi: 10.1016/j.celrep.2017.01.072.

8.
9.

Prevalence of ESBL-Producing Enterobacteriaceae in Pediatric Bloodstream Infections: A Systematic Review and Meta-Analysis.

Flokas ME, Karanika S, Alevizakos M, Mylonakis E.

PLoS One. 2017 Jan 31;12(1):e0171216. doi: 10.1371/journal.pone.0171216. eCollection 2017. Review.

10.

Colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae and risk for infection among patients with solid or haematological malignancy: a systematic review and meta-analysis.

Alevizakos M, Karanika S, Detsis M, Mylonakis E.

Int J Antimicrob Agents. 2016 Dec;48(6):647-654. doi: 10.1016/j.ijantimicag.2016.08.021. Epub 2016 Oct 6. Review.

PMID:
27746102
11.

Uncontrolled diabetes predicts poor response to novel antiandrogens.

Karantanos T, Karanika S, Gignac G.

Endocr Relat Cancer. 2016 Sep;23(9):691-8. doi: 10.1530/ERC-16-0222.

PMID:
27515296
12.

Caveolin-1 regulates hormone resistance through lipid synthesis, creating novel therapeutic opportunities for castration-resistant prostate cancer.

Karantanos T, Karanika S, Wang J, Yang G, Dobashi M, Park S, Ren C, Li L, Basourakos SP, Hoang A, Efstathiou E, Wang X, Troncoso P, Titus M, Broom B, Kim J, Corn PG, Logothetis CJ, Thompson TC.

Oncotarget. 2016 Jul 19;7(29):46321-46334. doi: 10.18632/oncotarget.10113.

13.

Systematic Review and Meta-analysis of Clinical and Economic Outcomes from the Implementation of Hospital-Based Antimicrobial Stewardship Programs.

Karanika S, Paudel S, Grigoras C, Kalbasi A, Mylonakis E.

Antimicrob Agents Chemother. 2016 Jul 22;60(8):4840-52. doi: 10.1128/AAC.00825-16. Print 2016 Aug.

14.

Fecal Colonization With Extended-spectrum Beta-lactamase-Producing Enterobacteriaceae and Risk Factors Among Healthy Individuals: A Systematic Review and Metaanalysis.

Karanika S, Karantanos T, Arvanitis M, Grigoras C, Mylonakis E.

Clin Infect Dis. 2016 Aug 1;63(3):310-8. doi: 10.1093/cid/ciw283. Epub 2016 May 3. Review. Erratum in: Clin Infect Dis. 2016 Sep 15;63(6):851.

PMID:
27143671
15.

Colonization With Methicillin-resistant Staphylococcus aureus and Risk for Infection Among Asymptomatic Athletes: A Systematic Review and Metaanalysis.

Karanika S, Kinamon T, Grigoras C, Mylonakis E.

Clin Infect Dis. 2016 Jul 15;63(2):195-204. doi: 10.1093/cid/ciw240. Epub 2016 Apr 18. Review.

PMID:
27090988
16.

Assessing the cardiovascular risk of hormonal therapy in patients with prostate cancer.

Karantanos T, Karanika S.

Ann Transl Med. 2016 Mar;4(5):99. doi: 10.21037/atm.2016.01.23. No abstract available.

17.

Prevalence and Clinical Outcomes of Clostridium difficile Infection in the Intensive Care Unit: A Systematic Review and Meta-Analysis.

Karanika S, Paudel S, Zervou FN, Grigoras C, Zacharioudakis IM, Mylonakis E.

Open Forum Infect Dis. 2015 Dec 1;3(1):ofv186. doi: 10.1093/ofid/ofv186. eCollection 2016 Jan.

18.

Risk factors for meticillin-resistant Staphylococcus aureus colonization in dialysis patients: a meta-analysis.

Karanika S, Zervou FN, Zacharioudakis IM, Paudel S, Mylonakis E.

J Hosp Infect. 2015 Nov;91(3):257-63. doi: 10.1016/j.jhin.2015.07.014. Epub 2015 Aug 28. Review.

PMID:
26428959
19.

GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells.

Karanika S, Karantanos T, Kurosaka S, Wang J, Hirayama T, Yang G, Park S, Golstov AA, Tanimoto R, Li L, Thompson TC.

Mol Cancer. 2015 Jun 19;14:122. doi: 10.1186/s12943-015-0395-0.

20.

Novel anti-androgen receptor signaling agents: Understanding the mechanisms of resistance.

Karanika S, Karantanos T, Yin J, Li L, Thompson TC.

Asian J Urol. 2014 Oct;1(1):30-39. doi: 10.1016/j.ajur.2015.04.004. Epub 2015 Apr 16. Review.

21.

DNA damage response and prostate cancer: defects, regulation and therapeutic implications.

Karanika S, Karantanos T, Li L, Corn PG, Thompson TC.

Oncogene. 2015 May 28;34(22):2815-22. doi: 10.1038/onc.2014.238. Epub 2014 Aug 18. Review.

22.

Targeting poly(ADP-ribose) polymerase and the c-Myb-regulated DNA damage response pathway in castration-resistant prostate cancer.

Li L, Chang W, Yang G, Ren C, Park S, Karantanos T, Karanika S, Wang J, Yin J, Shah PK, Takahiro H, Dobashi M, Zhang W, Efstathiou E, Maity SN, Aparicio AM, Li Ning Tapia EM, Troncoso P, Broom B, Xiao L, Lee HS, Lee JS, Corn PG, Navone N, Thompson TC.

Sci Signal. 2014 May 20;7(326):ra47. doi: 10.1126/scisignal.2005070.

23.

Immune response after laparoscopic colectomy for cancer: a review.

Karanika S, Karantanos T, Theodoropoulos GE.

Gastroenterol Rep (Oxf). 2013 Sep;1(2):85-94. doi: 10.1093/gastro/got014. Epub 2013 May 3.

24.

Do anastomotic leaks impair postoperative health-related quality of life after rectal cancer surgery? A case-matched study.

Marinatou A, Theodoropoulos GE, Karanika S, Karantanos T, Siakavellas S, Spyropoulos BG, Toutouzas K, Zografos G.

Dis Colon Rectum. 2014 Feb;57(2):158-66. doi: 10.1097/DCR.0000000000000040.

PMID:
24401876

Supplemental Content

Loading ...
Support Center